India, Sept. 11 -- ageas SA/NV,(AGES.BR, AGESY), a Belgian insurance group, on Friday completed the sale of its 30.95% stake in Maybank Ageas Holdings Berhad to Maybank for 1.1 billion euros in cash. ... Read More
India, Sept. 11 -- European stocks may struggle for direction at open on Friday as rising energy prices and Treasury yields added to concerns about the outlook for interest rates. As inflation risks ... Read More
India, Sept. 11 -- Emma "Baby Spice" Bunton and Geri "Ginger Spice" Halliwell-Horner reunite with Pumpkin Spice, portrayed by Rachel Dratch, in Dunkin's latest campaign celebrating the return of pumpk... Read More
India, Sept. 11 -- Power chipmaker Vicor Corp. (VICR) announced on Friday that it has acquired two sites in New Hampshire to build additional ChiP fabrication plants, expanding capacity to meet demand... Read More
India, Sept. 11 -- NEOJAPAN Inc. (3921.T) released earnings for its first half that Increased, from the same period last year The company's bottom line came in at JPY947 million, or JPY67.59 per shar... Read More
India, Sept. 11 -- Hikma Pharmaceuticals PLC (HKMPY,HIK.L), a drug manufacturer, on Thursday announced that regulators in the United States, Europe, and the UK have accepted for review its regulatory ... Read More
India, Sept. 11 -- Pharma Foods International Co Ltd (2929.T) reported earnings for its full year that Increased, from the same period last year The company's bottom line totaled JPY1.988 billion, or... Read More
India, Sept. 11 -- Indian shares were sharply lower in early trade on Friday as crude oil prices soared amid escalating tensions in West Asia, raising worries about India's import bill, inflation and ... Read More
India, Sept. 11 -- On Friday, MoneyHero Limited (MNY), an aggregation and comparison platform for insurance, reported a loss for the second quarter, compared to the profit in the previous year, due to... Read More
India, Sept. 11 -- Biotech and healthcare saw regulatory approvals, strategic partnerships, M&A activity, and a steady stream of clinical trial updates driving investor attention. Notable development... Read More